Your browser doesn't support javascript.
loading
A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
Leung-Theung-Long, Stéphane; Coupet, Charles-Antoine; Gouanvic, Marie; Schmitt, Doris; Ray, Aurélie; Hoffmann, Chantal; Schultz, Huguette; Tyagi, Sandeep; Soni, Heena; Converse, Paul J; Arias, Lilibeth; Kleinpeter, Patricia; Sansas, Benoît; Mdluli, Khisimuzi; Vilaplana, Cristina; Cardona, Pere-Joan; Nuermberger, Eric; Marchand, Jean-Baptiste; Silvestre, Nathalie; Inchauspé, Geneviève.
Afiliação
  • Leung-Theung-Long S; Transgene SA, Infectious Diseases department, Centre d'Infectiologie, Bât Domilyon, Lyon, France.
  • Coupet CA; Transgene SA, Infectious Diseases department, Centre d'Infectiologie, Bât Domilyon, Lyon, France.
  • Gouanvic M; Transgene SA, Infectious Diseases department, Centre d'Infectiologie, Bât Domilyon, Lyon, France.
  • Schmitt D; Transgene SA, Boulevard Gonthier d'Andernach, Parc d'innovation, Illkirch-Graffenstaden, France.
  • Ray A; Transgene SA, Infectious Diseases department, Centre d'Infectiologie, Bât Domilyon, Lyon, France.
  • Hoffmann C; Transgene SA, Boulevard Gonthier d'Andernach, Parc d'innovation, Illkirch-Graffenstaden, France.
  • Schultz H; Transgene SA, Boulevard Gonthier d'Andernach, Parc d'innovation, Illkirch-Graffenstaden, France.
  • Tyagi S; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Soni H; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Converse PJ; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Arias L; Unitat de Tuberculosi Experimental, Fundació Institut Germans Trias i Pujol, Universitat Autònoma de Barcelona, CIBERES, Crta Badalona, Catalonia, Spain.
  • Kleinpeter P; Transgene SA, Boulevard Gonthier d'Andernach, Parc d'innovation, Illkirch-Graffenstaden, France.
  • Sansas B; Transgene SA, Boulevard Gonthier d'Andernach, Parc d'innovation, Illkirch-Graffenstaden, France.
  • Mdluli K; Global Alliance for Tuberculosis Drug Development, New York, New York, United States of America.
  • Vilaplana C; Unitat de Tuberculosi Experimental, Fundació Institut Germans Trias i Pujol, Universitat Autònoma de Barcelona, CIBERES, Crta Badalona, Catalonia, Spain.
  • Cardona PJ; Unitat de Tuberculosi Experimental, Fundació Institut Germans Trias i Pujol, Universitat Autònoma de Barcelona, CIBERES, Crta Badalona, Catalonia, Spain.
  • Nuermberger E; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Marchand JB; Transgene SA, Boulevard Gonthier d'Andernach, Parc d'innovation, Illkirch-Graffenstaden, France.
  • Silvestre N; Transgene SA, Boulevard Gonthier d'Andernach, Parc d'innovation, Illkirch-Graffenstaden, France.
  • Inchauspé G; Transgene SA, Infectious Diseases department, Centre d'Infectiologie, Bât Domilyon, Lyon, France.
PLoS One ; 13(5): e0196815, 2018.
Article em En | MEDLINE | ID: mdl-29718990
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article